CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Rolke James Chief Executive Officer | Grant or award | +208,076 | 422,814 | ||
| 2026-08-17 | Chawla Lakhmir S Director | Grant or award | +32,011 | 44,169 | ||
| 2026-08-17 | Zygmont Chester Stanley III Chief Financial Officer | Grant or award | +208,073 | 208,073 | ||
| 2026-08-17 | Zygmont Chester Stanley III Chief Financial Officer | Gift | −208,073 | 0 | ||
| 2026-08-17 | Zygmont Chester Stanley III Chief Financial Officer | Gift | +208,073 | 300,136 | ||
| 2026-08-17 | ROPER JESS Director | Grant or award | +32,011 | 44,839 | ||
| 2026-08-17 | CARVER JENNIFER Director | Grant or award | +32,011 | 44,769 | ||
| 2026-04-30 | Rolke James Chief Executive Officer | Shares withheld for taxes | −10,115 | $1.13 | $11K | 214,738 |
| 2026-04-30 | Zygmont Chester Stanley III Chief Financial Officer | Shares withheld for taxes | −13,285 | $1.10 | $15K | 92,063 |
| 2026-02-04 | Zygmont Chester Stanley III Chief Financial Officer | Shares withheld for taxes | −13,100 | $1.65 | $22K | 105,348 |
| 2026-02-03 | ROPER JESS Director | Shares withheld for taxes | −1,591 | $1.85 | $3K | 12,828 |
| 2026-02-03 | Chawla Lakhmir S Director | Shares withheld for taxes | −2,261 | $1.85 | $4K | 12,158 |
| 2026-02-03 | CARVER JENNIFER Director | Shares withheld for taxes | −1,661 | $1.87 | $3K | 12,758 |
| 2026-02-03 | Rolke James Chief Executive Officer | Shares withheld for taxes | −8,521 | $1.86 | $16K | 224,853 |
| 2026-01-08 | Rolke James Chief Executive Officer | Grant or award | +532,829 | $0.90 | $480K | 933,489 |
| 2026-01-08 | Zygmont Chester Stanley III Chief Financial Officer | Grant or award | +78,145 | $0.90 | $70K | 473,790 |
| 2026-01-08 | CARVER JENNIFER Director | Grant or award | +41,981 | $0.90 | $38K | 57,669 |
| 2026-01-08 | ROPER JESS Director | Grant or award | +41,981 | $0.90 | $38K | 57,667 |
| 2026-01-08 | Chawla Lakhmir S Director | Grant or award | +41,981 | $0.90 | $38K | 57,667 |
| 2025-10-29 | Chawla Lakhmir S Director | Grant or award | +15,625 | $1.28 | $20K | 15,686 |
Page 1 of 4 · 64 trades